IRMD Stock Analysis: Buy, Sell, or Hold?
IRMD - iRadimed Corporation
$86.95
-0.21 (-0.24%)
▼
5d:
-5.99%
30d:
-11.07%
90d:
+0.07%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 07, 2026
0d
Get Alerted When IRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IRMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IRMD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$95.18
Based on 9.7% avg growth
INTRINSIC VALUE TODAY
$59.10
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRMD is currently trading at $86.95, which is considered oversold relative to its 30-day fair value range of $90.18 to $96.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 36.1) compared to its historical average (41.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRMD is showing sideways momentum. The price is currently testing key support at $85.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IRMD scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.00 (+35.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRMD is showing sideways momentum. The price is currently testing key support at $85.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IRMD scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.00 (+35.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$90.18 -
$96.60
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding IRMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.7% below Wall St target ($118.00)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$90.18 -
$96.60
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.48
(5.2%)
Support & Resistance Levels
Support Level
$85.00
Resistance Level
$94.77
Current Trend
Sideways
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
36.08
Wall Street Target
$118.00
(+35.7%)
Revenue Growth (YoY)
0.3%
Earnings Growth (YoY)
-9.3%
Profit Margin
26.7%
Valuation Discount vs History
-4.8% cheaper
PE vs Historical
36.1 vs 41.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.8%
(market-implied from PE analysis)
1-Year Target
$82.78
(-5%)
2-Year Target
$78.80
(-9%)
3-Year Target
$75.02
(-14%)
3-Yr Target (if PE normalizes)
(PE: 36→42)
$86.92
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 36.1, Growth: 15.3%)
$133.32
(+53%)
Base:
(SPY PE: 20.2, Growth: 15.3%)
$74.75
(-14%)
Bear:
(PE: 17.2, Growth: 15.3%)
$63.54
(-27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (49x PE), but valuation improves significantly next year (36x PE) as earnings recover.
Trailing PE: 48.69 | Current EPS (TTM): $1.79
Bull Case
$129.08
(+49%)
Analyst growth 34.6%, PE expands to 53.6
Base Case
$117.35
(+35%)
Market implied 34.6%, PE stable at 48.7
Bear Case
$59.27
(-32%)
Severe decline -20.0%, PE contracts to 41.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 36.1 to 41.8
Stabilization Target:
$100.74
(+15.9%)
PE Expansion Potential:
+15.9%
Share & Embed Analysis
Last updated: August 16, 2026 6:41 AM ET
Data refreshes hourly during market hours. Next update: 7:41 AM
Data refreshes hourly during market hours. Next update: 7:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Roger E Susi
SELL
2500 shares
2026-04-21
Roger E Susi
SELL
5000 shares
2026-04-20
Roger E Susi
SELL
2500 shares
2026-04-14
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$382 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 28 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 29 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 39 SELL |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 37 SELL |
Advanced IRMD Option Strategies
Professional options setups generated by AI based on today's IRMD price and gamma walls.
